Preoperative serum hepatitis B virus DNA was a risk factor for hepatocellular carcinoma recurrence after liver transplantation

Preoperative serum hepatitis B virus DNA was a risk factor for hepatocellular carcinoma recurrence after liver transplantation

Background Tumour characteristics and orthotopic liver transplantation (OLT) criteria are risks for recurrence of hepatocellular carcinoma (HCC). In Asia, most HCC is caused by chronic hepatitis B infection. Whether hepatitis B virus DNA (HBV DNA) is a risk factor for HCC recurrence after OLT is not...

Full description

Bibliographic Details
Main Authors:	Dali Zhang, Danni Feng, Minjuan Ren, Ying Bai, Zhenwen Liu, Hongbo Wang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-12-01
Series:	Annals of Medicine
Subjects:	Liver transplantation hepatocellular carcinoma hepatitis B virus DNA recurrence long-term survival
Online Access:	https://www.tandfonline.com/doi/10.1080/07853890.2022.2107233

Similar Items

Elevated Perioperative Transaminase Level Predicts Intrahepatic Recurrence in Hepatitis B-related Hepatocellular Carcinoma After Curative Hepatectomy
by: Yue-Sun Cheung, et al.
Published: (2008-04-01)

Delayed Hepatocellular Carcinoma Recurrence After Liver Transplantation: Comprehensive Clinical Characterization of Case Series
by: Wong TH, et al.
Published: (2022-10-01)

Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients
by: Jihye Kim, et al.
Published: (2020-10-01)

Imaging of hepatocellular carcinoma recurrence after liver transplantation
by: Giuseppe Mamone, et al.
Published: (2023-05-01)

Preoperative Alfa-Fetoprotein and Fibrinogen Predict Hepatocellular Carcinoma Recurrence After Liver Transplantation Regardless of the Milan Criteria: Model Development with External Validation
by: Nan Jiang, et al.
Published: (2018-07-01)

Long-term results of liver transplantation for hepatocellular carcinoma
by: M. Sh. Khubutia, et al.
Published: (2018-08-01)

Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma
by: Incheon Kang, et al.
Published: (2021-10-01)

Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablation
by: Liang‐He Lu, et al.
Published: (2020-05-01)

Efficacy and prognostic impact of preoperative risk factors for salvage liver transplantation and repeat hepatectomy in patients with early-stage recurrent hepatocellular carcinoma: a propensity score-matched analysis
by: Linfeng Yang, et al.
Published: (2025-02-01)

Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation
by: Simone Lasagni, et al.
Published: (2022-09-01)

Transjugular Intrahepatic Portosystemic Shunt Is Associated With Better Waitlist Management of Liver Transplant Candidates With Hepatocellular Carcinoma
by: Sofia El Hajji, et al.
Published: (2024-06-01)

Prognostic Value of Preoperative Serum Leucine Aminopeptidases in Hepatocellular Carcinoma Patients Who Underwent Liver Transplantation
by: Ren Q, et al.
Published: (2021-02-01)

Cellular Prion Protein Is Closely Associated with Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma
by: Mo-Jong Kim, et al.
Published: (2022-07-01)

Performance of eight predictive models for hepatocellular carcinoma recurrence after liver transplantation: A comparative study
by: Ajacio Bandeira de Mello Brandão, et al.
Published: (2024-03-01)

Predictive value of preoperative inflammatory indexes for postoperative early recurrence of hepatitis B-related hepatocellular carcinoma
by: Guo Wenpei, et al.
Published: (2023-07-01)

Imaging-Derived Biomarkers Integrated with Clinical and Laboratory Values Predict Recurrence of Hepatocellular Carcinoma After Liver Transplantation
by: Hoang TPT, et al.
Published: (2023-12-01)

Feasibility and outcomes of percutaneous radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma after liver transplantation: a single-center experience
by: Baoxian Liu, et al.
Published: (2020-01-01)

Peritoneal Recurrence of Initially Controlled Hepatocellular Carcinoma after Living Donor Liver Transplantation
by: Nariman Sadykov, et al.
Published: (2015-01-01)

Expression of Peptidyl Arginine Deiminase 2 Is Closely Associated with Recurrence in Patients with Hepatocellular Carcinoma
by: Sunho Uhm, et al.
Published: (2023-02-01)

Preoperative Prognostic Nutritional Index May Be a Strong Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation
by: Kornberg A, et al.
Published: (2022-07-01)

The management of post-transplantation recurrence of hepatocellular carcinoma
by: Luckshi Rajendran, et al.
Published: (2022-01-01)

Systemic Hepatic-Damage Index for Predicting the Prognosis of Hepatocellular Carcinoma after Curative Resection
by: Xing-hui Gao, et al.
Published: (2017-07-01)

Risk factors for early and late recurrence in hepatocellular carcinoma after liver transplantation
by: Fan Hsiu-Lung, et al.
Published: (2021-01-01)

Preoperative Noninvasive Prediction of Recurrence-Free Survival in Hepatocellular Carcinoma Using CT-Based Radiomics Model
by: Dai T, et al.
Published: (2024-11-01)

Is hepatocellular carcinoma viability important when using intraoperative blood salvage during liver transplantation?
by: Ahmed Nasser, et al.
Published: (2023-07-01)

Prediction of Non-Transplantable Recurrence After Liver Resection for Solitary Hepatocellular Carcinoma
by: Zhang C, et al.
Published: (2024-01-01)

Treatment of recurrent hepatitis C post-liver transplantation
by: Claudio Augusto Marroni
Published: (2010-01-01)

Sirolimus in Liver Transplant Recipients with Hepatocellular Carcinoma: An Updated Meta-Analysis
by: Zhi-Hua Zhang, et al.
Published: (2019-10-01)

Outcome of early vs. deferred antiviral treatment for recurrent hepatitis C in liver transplant recipients
by: Isabel Campos-Varela, et al.
Published: (2014-03-01)

Repeat hepatic resection combined with intraoperative radiofrequency ablation versus repeat hepatic resection alone for recurrent and multiple hepatocellular carcinoma patients meeting the Barcelona Clinic Liver Cancer stage A: A propensity score‐matched analysis
by: Yang Huang, et al.
Published: (2023-04-01)

Characterization of hepatocellular carcinoma recurrence after liver transplantation: Perioperative prognostic factors, patterns, and outcome
by: Kun-Ming Chan, et al.
Published: (2011-07-01)

Outcomes of Living Donor Liver Transplantation in Patients With a History of Ruptured Hepatocellular Carcinoma
by: Hwi Yeol Lee, et al.
Published: (2021-10-01)

Radiofrequency ablation versus hepatic resection for recurrent hepatocellular carcinoma: an updated meta-analysis
by: Daopeng Yang, et al.
Published: (2020-11-01)

Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C
by: Naoki Kawagishi, et al.
Published: (2023-01-01)

Comparisons of Viral Etiology and Outcomes of Hepatocellular Carcinoma Undergoing Liver Resection between Taiwan and Vietnam
by: Song-Huy Nguyen-Dinh, et al.
Published: (2022-11-01)

Efficiency of Antiviral Therapy for Recurrence of Chronic Hepatitis C in Patients Undergoing Liver Transplantation
by: A. A. Sukhoruk, et al.
Published: (2014-09-01)

Progression of hepatic aspergillosis following second renal transplantation in a patient with recurrent glomerulonephritis
by: Krishan L Gupta, et al.
Published: (2012-01-01)

The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation
by: Jie Zhou, et al.
Published: (2024-02-01)

Survival benefits of interferon-based therapy in patients with recurrent hepatitis C after orthotopic liver transplantation
by: L.P. Zanaga, et al.

Prognosis of Hepatocellular Carcinoma after Liver Transplantation: Comparative Analysis with Partial Hepatectomy
by: Kyuho Lee, et al.
Published: (2017-01-01)